Free Trial

Seres Therapeutics (MCRB) SEC Filings & 10K Form

$0.91
-0.04 (-4.21%)
(As of 05/21/2024 ET)

Recent Seres Therapeutics SEC Filings

DateFilerForm TypeView
05/17/2024
7:16 PM
Ege David S. (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
7:17 PM
Henn Matthew R. (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
7:18 PM
Seres Therapeutics (Issuer)
Young Teresa L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
7:18 PM
Seres Therapeutics (Issuer)
Shaff Eric D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
7:23 PM
Seres Therapeutics (Issuer)
von Moltke Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
7:14 PM
DesRosier Thomas (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
9:00 AM
Seres Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2024
6:05 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
4:18 PM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2024
6:00 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2024
3:45 PM
Berenson Stephen (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
3:45 PM
Ausiello Dennis A (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
3:45 PM
Dere Willard H (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
3:45 PM
Fraser Claire (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
3:45 PM
Biondi Paul (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
3:45 PM
Kender Richard N (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
3:45 PM
Graves Kurt (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
3:30 PM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2024
11:21 AM
BlackRock Inc. (Filed by)
Seres Therapeutics (Subject)
Form SC 13G/A
03/27/2024
3:20 PM
Seres Therapeutics (Issuer)
Thorell Marella (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
9:01 AM
Seres Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/05/2024
9:13 AM
Seres Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/05/2024
9:18 AM
Seres Therapeutics (Filer)
Form DEF 14A
03/05/2024
6:05 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2024
6:06 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2024
8:48 PM
DesRosier Thomas (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
8:42 PM
Seres Therapeutics (Issuer)
Shaff Eric D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
8:21 PM
Seres Therapeutics (Issuer)
von Moltke Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
8:29 PM
Seres Therapeutics (Issuer)
Young Teresa L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
8:31 PM
Henn Matthew R. (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
8:13 PM
Arkowitz David (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
8:15 PM
Ege David S. (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
11:23 AM
JANUS HENDERSON GROUP PLC (Filed by)
Seres Therapeutics (Subject)
Form SC 13G/A
02/09/2024
8:49 AM
FMR LLC (Filed by)
Seres Therapeutics (Subject)
Form SC 13G/A
01/30/2024
3:01 PM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2024
4:25 PM
BlackRock Inc. (Filed by)
Seres Therapeutics (Subject)
Form SC 13G
01/10/2024
6:00 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2024
6:05 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2023
11:57 AM
FEDERATED HERMES, INC. (Filed by)
FEDERATED HERMES, INC. (Filed by)
Seres Therapeutics (Subject)
Form SC 13G/A
11/02/2023
9:00 AM
Seres Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/02/2023
6:05 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Warren Buffett's "mystery stock" (Ad)

WARNING: Read This Before the Next Fed Meeting Investors are looking to the Fed with high hopes for interest rate relief. Unfortunately, many have no idea there's another major story unfolding right now, one that could be worth $40 trillion.

This Wall Street millionaire just stepped forward with all the details, and how it could make some
10/31/2023
8:36 PM
Henn Matthew R. (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2023
8:36 PM
Seres Therapeutics (Issuer)
von Moltke Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2023
8:39 PM
Ege David S. (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2023
8:39 PM
DesRosier Thomas (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2023
8:39 PM
Arkowitz David (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2023
8:40 PM
Seres Therapeutics (Issuer)
Young Teresa L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2023
8:40 PM
Seres Therapeutics (Issuer)
Shaff Eric D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2023
8:43 PM
Cloghessy Paula (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2023
6:00 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2023
11:15 PM
Seres Therapeutics (Filer)
Form EFFECT
08/08/2023
9:01 AM
Seres Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2023
6:05 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2023
7:00 AM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2023
4:29 PM
Ausiello Dennis A (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
4:35 PM
Biondi Paul (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
4:21 PM
Dere Willard H (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
4:21 PM
Kender Richard N (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
4:22 PM
Graves Kurt (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
4:24 PM
Behar Gregory (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
4:25 PM
Fraser Claire (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
4:25 PM
Berenson Stephen (Reporting)
Seres Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:05 PM
Seres Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:MCRB) was last updated on 5/21/2024 by MarketBeat.com Staff

From Our Partners